Welcome to our dedicated page for PARK HA BIOLOGICAL TECHNOLOGY news (Ticker: BYAH), a resource for investors and traders seeking the latest updates and insights on PARK HA BIOLOGICAL TECHNOLOGY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PARK HA BIOLOGICAL TECHNOLOGY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PARK HA BIOLOGICAL TECHNOLOGY's position in the market.
Park Ha Biological Technology (NASDAQ: PHH) will change its Nasdaq ticker symbol to BYAH, effective Tuesday, October 28, 2025. Trading of the Company’s ordinary shares will move from the symbol PHH to BYAH on that date. The Company said the change aims to avoid confusion with a delisted issuer that previously used PHH and to strengthen long-term brand value. No action is required by existing shareholders. The Company will remain listed on Nasdaq and the CUSIP will remain unchanged. The announcement contains standard forward-looking statement disclaimers about risks and uncertainties.
FAQ
What is the current stock price of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?
